Marco Lodrini

Histone deacetylase 10 promotes autophagy-mediated cell survival

Ina Oehme, Jan-Peter Linke, Barbara C. Böck et al. · Proceedings of the National Academy of Sciences · 2013 · 217 citations · Full text

Life Sciences, Cell Biology, Oncology +17

HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth

Till Milde, Ina Oehme, Andrey Korshunov et al. · Clinical Cancer Research · 2010 · 193 citations

Medicine, Molecular Biology, Oncology +13

HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment

Till Milde, Marco Lodrini, Larissa Savelyeva et al. · Journal of Neuro-Oncology · 2012 · 131 citations

Life Sciences, Molecular Biology, Oncology +14

HDAC11 is a novel drug target in carcinomas

Hedwig E. Deubzer, Marie C. Schier, Ina Oehme et al. · International Journal of Cancer · 2012 · 109 citations

Medicine, Oncology, Pharmacology +12

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions

Karin Schmelz, Joern Toedling, Matthew R. Huska et al. · Nature Communications · 2021 · 101 citations · Full text

Medicine, Genetics, Oncology +17